Search research articles
Contact Us
Filters
Showing results (71-80 of 236) with videos related to
Page
of 24
Sort By:
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
February 24, 2001
Pharmacological characterisation of the decrease in 5-HT synthesis in the mouse brain evoked by the selective serotonin re-uptake inhibitor citalopram
C Stenfors, H Yu, S B Ross
Thrombosis and Haemostasis
|
October 1, 1994
Why is plasma fibrinogen a cardiovascular risk factor?
M C Scrutton, S B Ross-Murphy
Journal of Neural Transmission
|
January 1, 1984
Effect of destruction of central noradrenergic and serotonergic nerve terminals by systemic neurotoxins on the long-term effects of antidepressants on beta-adrenoceptors and 5-HT2 binding sites in the rat cerebral cortex
H Hall, S B Ross, M Sällemark
Behavioral and Neural Biology
|
May 1, 1985
Active and passive avoidance following the administration of systemic DSP4, xylamine, or p-chloroamphetamine
T Archer, G Jonsson, S B Ross
Acta Psychiatrica Scandinavica. Supplementum
|
January 1, 1974
Plasma dopamine-beta-hydrozylase in Huntington's chorea
B Mattsson, L Wetterberg, S B Ross
Psychiatry Research
|
October 1, 1979
Acute effects of zimelidine and alaproclate, two inhibitors of serotonin uptake, on neuroendocrine function
E Syvälahti, P Eneroth, S B Ross
Medical Biology
|
June 1, 1975
5-Hydroxytryptamine and learning: long-term effects of P-chloroamphetamine on acquisition
S Ogren, S B Ross, L Baumann
European Journal of Pharmacology
|
July 10, 1981
Regional in vivo binding of [3H]N-propylnorapomorphine in the mouse brain. Evidence for labelling of central dopamine receptors
C Köhler, K Fuxe, S B Ross
Neuropharmacology
|
March 23, 2000
Enhanced 5-HT metabolism and synthesis rate by the new selective r5-HT1B receptor antagonist, NAS-181 in the rat brain
C Stenfors, H Yu, S B Ross
Biorheology
|
May 1, 1993
Polysaccharide strong and weak gels
S B Ross-Murphy, K P Shatwell
Page
of 24
Search research articles
Search
Showing results (71-80 of 236) with videos related to
Sort By:
Page
of 24
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
February 24, 2001
Pharmacological characterisation of the decrease in 5-HT synthesis in the mouse brain evoked by the selective serotonin re-uptake inhibitor citalopram
C Stenfors, H Yu, S B Ross
Thrombosis and Haemostasis
|
October 1, 1994
Why is plasma fibrinogen a cardiovascular risk factor?
M C Scrutton, S B Ross-Murphy
Journal of Neural Transmission
|
January 1, 1984
Effect of destruction of central noradrenergic and serotonergic nerve terminals by systemic neurotoxins on the long-term effects of antidepressants on beta-adrenoceptors and 5-HT2 binding sites in the rat cerebral cortex
H Hall, S B Ross, M Sällemark
Behavioral and Neural Biology
|
May 1, 1985
Active and passive avoidance following the administration of systemic DSP4, xylamine, or p-chloroamphetamine
T Archer, G Jonsson, S B Ross
Acta Psychiatrica Scandinavica. Supplementum
|
January 1, 1974
Plasma dopamine-beta-hydrozylase in Huntington's chorea
B Mattsson, L Wetterberg, S B Ross
Psychiatry Research
|
October 1, 1979
Acute effects of zimelidine and alaproclate, two inhibitors of serotonin uptake, on neuroendocrine function
E Syvälahti, P Eneroth, S B Ross
Medical Biology
|
June 1, 1975
5-Hydroxytryptamine and learning: long-term effects of P-chloroamphetamine on acquisition
S Ogren, S B Ross, L Baumann
European Journal of Pharmacology
|
July 10, 1981
Regional in vivo binding of [3H]N-propylnorapomorphine in the mouse brain. Evidence for labelling of central dopamine receptors
C Köhler, K Fuxe, S B Ross
Neuropharmacology
|
March 23, 2000
Enhanced 5-HT metabolism and synthesis rate by the new selective r5-HT1B receptor antagonist, NAS-181 in the rat brain
C Stenfors, H Yu, S B Ross
Biorheology
|
May 1, 1993
Polysaccharide strong and weak gels
S B Ross-Murphy, K P Shatwell
Page
of 24